Free Communications - Diagnostics and Management 1

Tuesday, December 4, 2018
Free Communications
FC 10 1:30 PM > 3:05 PM Free Communications - Diagnostics and Management 1 5C

1:30 PM FC 10-01 Incidence of cervical cancer and other cancers after treatment of CIN: a systematic review and meta-analysis > E. Evangelos PARASKEVAIDIS 1:37 PM FC 10-02 Is high risk human papillomavirus (HR-HPV) testing reliable for the follow-up of women treated for glandular neoplasia and micro-invasive cancer > K. Kate CUSCHIERI 1:44 PM FC 10-03 High correlation between clearance of high-risk HPV strains after LLETZ and absence of residual disease in patients with early stage cervical cancer > E. Efraim SIEGLER 1:51 PM FC 10-04 Test of cure after leep for cervical intraepithelial neoplasia > A. Annu Heinonen 1:58 PM FC 10-05 Role of DNA HPV test in the follow-up of women undergoing excisional surgical procedures of cervical cancer precursor lesions > M. Maricy Tacla 2:05 PM FC 10-06 The role of colposcopy at twelve months after excision of the transformation zone > F. Filipa De Castro Coelho 2:12 PM FC 10-07 Colposcopic and histopathologic evaluation of women aged 56-64 with HPV-persistence 1 and 3 years, respectively, from the organized primary HPV screening in Sweden > K. Kristina Elfgren 2:19 PM FC 10-08 Colposcopy evaluation at the time of LEEP may avoid unnecessary treatment > A. Aureli Torné 2:26 PM FC 10-09 HSIL in pregnancy –observation or LLETZ in the first 15 weeks the safety of LLETZ in the first 15 weeks of pregnancy > E. Efraim SIEGLER 2:33 PM FC 10-10 The role of SWEDE score and modified REID colposcopic index in the prediction of CIN3+ lesions > E. Erik Kudela 2:40 PM FC 10-11 Colpoconnect: user-centered development for a healthcare app to decrease barriers to colposcopy attendance in a rural Canadian setting > S. Sheona Mitchell-Foster 2:47 PM FC 10-12 Outcomes of conservative management in women with transformation zone excision (TZE) specimens with positive margins > J. Joana Lyra 2:54 PM FC 10-13 Justifying conservative management of CIN2 in women <25 years a population-based study > D. Diede Loopik

Copyright © key4events - All rights reserved